We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksResolute Mining Regulatory News (RSG)

Share Price Information for Resolute Mining (RSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.20
Bid: 21.80
Ask: 22.40
Change: -0.20 (-0.89%)
Spread: 0.60 (2.752%)
Open: 22.00
High: 22.40
Low: 22.00
Prev. Close: 22.40
RSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Resolute equity raising to repay bridge loan

21 Jan 2020 07:00

RNS Number : 4286A
Resolute Mining Limited
21 January 2020
 

21 January 2020

Resolute Mining Limited

(Resolute or the Company)

 

Resolute to repay Toro Gold Bridge Facility

Equity Raising of up to A$196 million

Institutional Placement + Share Purchase Plan 

`

Highlights

·; Resolute has agreed with Taurus Funds Management Pty Limited to repay all amounts outstanding under the US$130 million Toro Gold bridge facility prior to the due date for repayment of 31 January 2020

·; Repayment to be funded by an Equity Raising of up to A$196 million comprising:

o Fully underwritten Institutional Placement to raise A$146 million (Tranche 1 Institutional Placement);

o Placement to the ICM Limited Group, Resolute's largest Shareholder, and Resolute's Directors, to raise A$25 million, subject to Resolute shareholder approval (Tranche 2 Placement); and

o A share purchase plan (SPP) offered to Resolute Shareholders residing in Australia and New Zealand, subject to an individual limit of A$30,000, to raise up to A$25 million

·; Shares in the Equity Raising to be issued at A$1.10 per share, representing a 6.4% discount to the last closing price of A$1.175 per share and a 7.0% discount to the 5-day VWAP of A$1.183 per share

·; Resolute Directors to participate in the Equity Raising for a total of up to A$500,000

·; Resolute's largest shareholder, ICM Limited Group, has subscribed to maintain its approximate pro-rata shareholding in the Company

·; Equity Raising will strengthen Resolute's balance sheet, reduce interest costs and debt fees, and support the refinancing of Resolute's existing senior debt facilities expected to be completed during the current quarter

 

NOT FOR RELEASE IN THE UNITED STATES

Resolute Mining Limited (ASX/LSE: RSG, Resolute or the Company) is pleased to announce the Company has agreed with Taurus Funds Management Pty Limited (Taurus) to repay all amounts outstanding under the US$130 million Toro Gold acquisition finance facility prior to the due date for repayment of 31 January 2020. The repayment will be funded by an equity raising to raise up to approximately A$196 million consisting of a fully underwritten institutional placement to raise A$146 million (Tranche 1 Institutional Placement), an additional A$25 million placement to Resolute's Directors and largest shareholder, ICM Limited Group (ICM Limited) (Tranche 2 Placement), and a SPP to raise up to A$25 million (collectively, the Equity Raising).

The Tranche 1 Institutional Placement will result in the issue of approximately 132.7 million new ordinary shares in Resolute (Tranche 1 Institutional Placement Shares) using the Company's available placement capacity. The Tranche 1 Institutional Placement Shares will be issued at a price of A$1.10 per share. The underwritten Tranche 1 Institutional Placement is being conducted through a bookbuild process that will be launched immediately following this announcement and is expected to close on Tuesday, 21 January 2020.

Under the Tranche 2 Placement, the Company proposes to issue approximately 22.7 million new ordinary shares in Resolute (Tranche 2 Placement Shares) at the same issue price as the Tranche 1 Institutional Placement Shares. Resolute's Directors have agreed to participate in the Equity Raising for up to A$500,000 in total. The issue of Tranche 2 Placement Shares to ICM Limited will enable ICM Limited to maintain its approximate pro-rata shareholding in the Company.

The issue price of A$1.10 per share represents a:

·; 6.4% discount to the closing price on Monday, 20 January 2020 of Resolute shares of A$1.175; and

·; 7.0% discount to Resolute's 5-day trading Volume Weighted Average Price (VWAP) of A$1.183.

Resolute's Managing Director and CEO, Mr John Welborn said: "The ability to entirely repay the Toro Gold acquisition facility will save Resolute extension fees and interest payments. More importantly, today's equity raising will support and enable the complete refinancing of our debt facilities during the current quarter. Completion of the equity placement, and the refinancing of our senior syndicated loan facilities, will enable the Company to simplify its capital structure and facilitate the retirement of debt facilities provided by Taurus.

"The SPP provides our eligible shareholders, along with the institutional shareholders who are participating in the placement, the opportunity to increase their shareholding in Resolute on attractive terms at a pivotal point in the Company's life cycle. Strong production guidance, a significant reduction in capital expenditure, operating assets which are now generating positive cashflows, and a stronger balance sheet with a greatly reduced debt burden, provides Resolute shareholders the opportunity for a positive re-rate."

The proceeds from the Equity Raising are intended to be used, subject to consent from Resolute's bankers, to fully repay the US$130 million Toro Gold bridge facility which was provided by Taurus (see ASX Announcement dated 31 July 2019). The facility attracts an interest rate of 9% per annum and is due for repayment on 31 January 2020.

The Tranche 1 Institutional Placement is within Resolute's available capacity under Australian Securities Exchange (ASX) Listing Rule 7.1 and accordingly shareholder approval is not required. The issue of the Tranche 2 Placement Shares to ICM Limited and to Resolute's Directors for up to A$500,000 is subject to Resolute Shareholder approval at the Company's Extraordinary General Meeting (EGM) expected to be held on 27 February 2020.

Resolute expects the trading halt on the ASX to be lifted upon announcement of the completion of the Tranche 1 Institutional Placement, which is expected to occur on Thursday, 23 January 2020. Settlement of the Tranche 1 Institutional Placement is expected to occur on Wednesday, 29 January 2020, with the Tranche 1 Institutional Placement Shares to commence trading on the ASX on Thursday, 30 January 2020. All shares to be issued will rank pari passu with Resolute's existing shares with effect from their issue.

In London, an application will be made for admission of all shares issued as part of the Equity Raising to the Official List of the FCA, standard segment, and to trading on the London Stock Exchange's Main Market for Listed Securities (LSE Admission) in due course. LSE Admission of the shares in the Tranche 1 Institutional Placement will require the publication of a FCA approved Prospectus. A Prospectus is being prepared and a further announcement will be made regarding the timing for LSE Admission following the approval and publication of the Prospectus.

Important information regarding the Equity Raising, including the offer restrictions applicable to the Equity Raising, are outlined in the Resolute Investor Presentation released today.

Share Purchase Plan

Resolute will offer all eligible existing Shareholders (including retail Shareholders) who were on Resolute's share register at 4.00pm (AWST) on Monday, 20 January 2020 with registered addresses in Australia or New Zealand the opportunity to apply for new Resolute shares through a Share Purchase Plan (SPP) without brokerage fees.

Resolute proposes to raise up to A$25 million via the SPP and the offer price under the SPP will also be A$1.10 per share.

The application for new shares under the SPP will be capped at the statutory maximum allowed of A$30,000 per eligible Shareholder. The SPP offer period will open on Monday, 3 February 2020 and close at 2:00pm (AWST) on Friday, 21 February 2020, subject to Resolute's discretion to amend these dates. Shares issued under the SPP will rank equally with Resolute's existing shares with effect from their issue. The terms and conditions of the SPP will be set out in an SPP Offer Booklet and despatched to eligible Resolute Shareholders by their preferred method of contact as well as a separate announcement to the ASX in due course. Participation in the SPP is optional and Resolute reserves the right to scale back any applications under the SPP.

Key Dates of the Equity Raising

Record date (for identifying shareholders entitled to participate in the SPP)

4.00pm, Monday, 20 January

Trading halt and announcement of Equity Raise, Tranche 1 Institutional Placement, Tranche 2 Placement and SPP

Tuesday, 21 January

Completion of Tranche 1 Institutional Placement, trading halt lifted

Thursday, 23 January

Tranche 2 Placement EGM Despatch Date

Wednesday, 29 January

Settlement of Trance 1 Institutional Placement

Wednesday, 29 January

Tranche 1 Institutional Placement Shares commence trading on ASX

Thursday, 30 January

SPP Offer opens

Monday, 3 February

SPP Offer closes

Friday, 21 February

Completion of SPP Offer

Wednesday, 26 February

Tranche 2 Placement EGM Date

Thursday, 27 February

Settlement of Tranche 2 Placement (subject to shareholder approval)

Friday, 28 February

Quotation of Tranche 2 Placement Shares on ASX (subject to shareholder approval)

Tuesday, 3 March

SPP Shares commence trading on ASX

Wednesday, 4 March

Note: Dates and times are indicative only and subject to change without notice. Resolute reserves the right to alter the dates in this presentation at its discretion and without notice, subject to the ASX Listing Rules and Corporations Act 2001 (Cth). All dates refer to 2020 and time is Australian Western Standard Time.

Advisers

Canaccord Genuity (Australia) Limited is acting as global lead manager, sole underwriter and joint bookrunner to the Placement. Joh. Berenberg, Gossler & Co. KG, London Branch is acting as co-lead manager and joint bookrunner to the Placement. Resolute's legal advisors are DLA Piper in Australia and Bryan Cave Leighton Paisner in the United Kingdom.

Additional Information

Further information concerning the Equity Raising is contained in the Resolute Investor Presentation released to the ASX today or is available on the company's website www.rml.com.au. Nothing contained in this announcement constitutes investment, legal, tax or other advice. You should seek appropriate professional advice before making any investment decision.

Conference Call

Resolute advises that Managing Director and CEO, Mr John Welborn, will host a Conference Call for investors, analysts and media on Tuesday, 21 January 2020 at 08:00AM (AWST, Perth) / 11:00AM (AEDT, Sydney), to discuss the Company's Equity Raising and December 2019 Quarterly Activities Report. The call will conclude with a question and answer session.

Australia Access Number: 1800 123 296

Conference ID: 2167834

Canada

1855 5616 766

New Zealand

0800 452 782

China

4001 203 085

Singapore

800 616 2288

Hong Kong

30082034

United Kingdom

0808 234 0757

Japan

0120 994 669

United States

1855 293 1544

For all other countries, please use the International Access Number: +61 2 8038 5221

Please dial in five minutes prior to the conference start time and provide the operator with your name and the Conference ID as shown above. To ask a question, please dial "*1" (star, 1) on your telephone keypad.

The Conference Call will be streamed live at http://www.openbriefing.com/OB/3650.aspx

Disclaimer

This announcement has been prepared for publication in Australia and may not be released to US wire services or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. Any securities described in this announcement have not been, and will not be, registered under the US Securities Act of 1933 and may not be offered or sold in the United States except in transactions exempt from, or not subject to, registration under the US Securities Act and applicable US state securities laws.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (MAR). Upon the publication of this announcement via a Regulatory Information Service (RIS), this inside information is now considered to be in the public domain.

EEA Member States

This announcement is directed at and is only being distributed to persons in member states of the European Economic Area who are "qualified investors", as defined in article 2.1(e) of the Prospectus Directive (Directive 2003/71/EC), as amended (the "Prospectus Directive"), including any relevant implementing measure in each member state of the European Economic Area which has implemented the Prospectus Directive. No other person should act on or rely on this Announcement and persons distributing this Announcement must satisfy themselves that it is lawful to do so.

Notice to Distributors

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the New Shares have been subject to a product approval process, which has determined that such securities are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment").

Notwithstanding the Target Market Assessment, distributors should note that: the price of the New Shares may decline and investors could lose all or part of their investment; the New Shares offer no guaranteed income and no capital protection; and an investment in the New Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom.

The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Institutional Placement. Furthermore, it is noted that, notwithstanding the Target Market, Assessment, Canaccord and Berenberg are only procuring investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability of appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the New Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the New Shares and determining appropriate distribution channels.

 

Contact Information

Resolute

John Welborn, Managing Director & CEO

Jeremy Meynert, General Manager - BD & IR

Telephone: +61 8 9261 6100

Email: contact@rml.com.au

Web: www.rml.com.au

Berenberg (UK Corporate Broker)

Matthew Armitt / Jennifer Wyllie / Detlir Elezi

Telephone: +44 20 3207 7800

 

Tavistock (UK Public Relations)

Jos Simson / Emily Moss / Annabel de Morgan / Oliver Lamb

Telephone: +44 207 920 3150 / +44 778 855 4035

Email: resolute@tavistock.co.uk

About Resolute

Resolute is a successful, dividend paying gold miner with more than 30 years of experience as an explorer, developer and operator of gold mines in Australia and Africa which have produced more than 8 million ounces of gold.

Resolute's guidance for FY20 is 500,000 ounces at an AISC of US$980 per ounce.

Resolute owns four gold mines and has a Global Mineral Resource base of more than 18 million ounces of gold. Its flagship asset is the world class Syama Gold Mine in Mali (Syama) which can produce more than 300,000 ounces of gold per annum from existing processing infrastructure. Resolute is currently commissioning the world's first fully automated underground mine at Syama which will deliver a low cost, large scale operation with a mine life beyond 2032. The Mako Gold Mine in Senegal is a high quality, low cost asset with average annual production of approximately 140,000 ounces of gold. The Ravenswood Gold Mine in Australia (Ravenswood) and the Bibiani Gold Mine in Ghana are existing large scale assets which provide Resolute with significant optionality, noting that definitive agreements have been entered into to sell Ravenswood for up to A$300 million.

Resolute trades on the Australian Securities Exchange (ASX) and the London Stock Exchange (LSE) under the ticker RSG.

Authorised by Mr John Welborn, Managing Director & CEO

 

ASX/LSE: RSG Capital Summary

Fully Paid Ordinary Shares: 903,153,734

Current Share Price (ASX):A$1.18 as at 20 January 2020

Market Capitalisation: A$1.1 Billion

FY19 Guidance (to 31 December):

500,000oz @ AISC US$980/oz

Board of Directors

Mr Martin Botha Non-Executive ChairmanMr John Welborn Managing Director & CEO

Ms Yasmin Broughton Non-Executive Director

Mr Mark Potts Non-Executive Director

Ms Sabina Shugg Non-Executive Director

Mr Peter Sullivan Non-Executive Director

Contact

John Welborn Managing Director & CEO

Jeremy Meynert GM - BD & IRLevel 2, Australia Place | 15-17 William StPerth, Western Australia 6000T: +61 8 9261 6100 | F: +61 8 9322 7597E: contact@rml.com.au

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEISMFESSEIF
Date   Source Headline
20th May 20229:39 amRNSDetails of Voting at Annual General Meeting
9th May 20227:00 amRNSMining Indaba Presentation
28th Apr 20227:00 amRNSMarch 2022 Quarterly Activities Report
26th Apr 20228:27 amRNSQuarterly Conference Call Details
19th Apr 20227:00 amRNSResolute COO Terry Holohan to be appointed CEO
19th Apr 20227:00 amRNSAppendix 3Z Stuart Gale
19th Apr 20227:00 amRNSAnnual General Meeting Withdrawal of Resolutions
14th Apr 20227:00 amRNSAGM Notice of Access
14th Apr 20227:00 amRNSNotice of Annual General Meeting
4th Apr 20227:41 amRNSNotice of ceasing to be a substantial holder
1st Apr 20228:41 amRNSAnnual General Meeting Advance Notice
1st Apr 20227:00 amRNSSuccessful completion of Syama sulphide shutdown
30th Mar 20222:45 pmRNSReport on Payments to Governments
29th Mar 20228:14 amRNSCorporate Governance Statement & Appendix 4G
29th Mar 20228:10 amRNS2021 Sustainability Report
29th Mar 20228:07 amRNS2021 Annual Report
10th Mar 20227:00 amRNSSuccessful Extension of Revolving Credit Facility
4th Mar 20227:00 amRNSLife of Mine Production Update
4th Mar 20227:00 amRNSOre Reserves and Mineral Resource Statement
24th Feb 20227:00 amRNSPreliminary Financial Results Presentation
24th Feb 20227:00 amRNSAppendix 4E Preliminary Final Report
24th Feb 20227:00 amRNSPreliminary Final Report
22nd Feb 20228:37 amRNSPreliminary Results Conference Call Details
17th Feb 20228:25 amRNSTabakoroni Resource Increases 40%
8th Feb 20224:41 pmRNSSecond Price Monitoring Extn
8th Feb 20224:35 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSSale of Orca Shares
20th Jan 20227:00 amRNSQuarterly Activities Report
18th Jan 20229:07 amRNSDec 2021 Quarterly Conference Calls - amended date
18th Jan 20227:52 amRNSDecember 2021 Quarterly Conference Calls
11th Jan 20227:00 amRNSOperational Update
8th Dec 20217:00 amRNSTotal Voting Rights
3rd Dec 202110:24 amRNSIssue of Equity
29th Nov 20217:00 amRNSChange of substantial holder interests
29th Nov 20217:00 amRNSMacquarie Australia Conference Presentation
23rd Nov 20217:00 amRNSIssue of Equity
29th Oct 20217:00 amRNSAppendix 3X - Simon Jackson
29th Oct 20217:00 amRNSAppendix 3Z - Yasmin Broughton
29th Oct 20217:00 amRNSDirector Appointment and Resignation
29th Oct 20217:00 amRNSSeptember 2021 Quarterly Activities Statement
28th Oct 20217:00 amRNSNotice of Results
27th Sep 20217:00 amRNSSyama Sulphide Processing Circuit Update
13th Sep 202110:36 amRNSResolute Presentation at Gold Forum Americas 2021
10th Sep 20217:00 amRNSUS$30 million voluntary debt repayment
10th Sep 20217:00 amRNSAppendix 3Y - Mark Potts
9th Sep 202111:11 amRNSAppendix 3Y Mark Potts
1st Sep 20217:00 amRNSPresentation at Africa Down Under Conference
27th Aug 20217:00 amRNS2021 Half Year Financial Results Summary
27th Aug 20217:00 amRNSHalf Year Financial Results and Accounts
27th Aug 20217:00 amRNS2021 Half Year Financial Results Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.